TITLE

Manufacturers Back Innovation Initiatives

AUTHOR(S)
Wechsler, Jill
PUB. DATE
June 2012
SOURCE
Pharmaceutical Technology;Jun2012, Vol. 36 Issue 6, p26
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article offers information on the U.S. government regulations and programs related to testing, regulation, and development of medical products. It mentions the private-public collaboration between National Institute of Health (NIH), U.S. Health and Human Services, and pharmaceutical companies that seeks to find uses for abandoned compounds. It states that regulations aim to speed up review of medical products and elimination of hurdles for market approval.
ACCESSION #
76352817

 

Related Articles

  • Government Cracks Down on Conflicts of Interest.  // Pharmaceutical Executive;Mar2005, Vol. 25 Issue 3, p22 

    Reports on the restriction of the U.S. Department of Health and Human Services to the staff at the U.S. National Institutes of Health in their consultation with the pharmaceutical industry, hospitals, insurers and healthcare providers in the U.S. Reason behind the restriction; Requirements...

  • NIH-Biopharm Interactions and the New NIH Conflict-of-lnterest Regulations. Young, Howard A. // BioPharm International;Jun2005, Vol. 18 Issue 6, p90 

    Reports on the impact of the Department of Health and Human Services ethics rules for the National Institutes of Health (NIH) employees on the biopharmaceutical industry in the U.S. Limits on NIH employee ownership of stock in the biotechnology and pharmaceutical industry; Decline in the number...

  • Drug Safety Fears May Limit Reimporting and Shape R&D. Wechsler, Jill // Pharmaceutical Technology;Feb2005, Vol. 29 Issue 2, p26 

    The article reports that the growing alarm over harmful side effects related to an increasing number of popular prescription drugs has affected critical issues for pharmaceutical manufacturers. The National Institutes of Health has recently halted important clinical trials because of fear that...

  • Stem Cell Politics: Difficult Choices for the White House and Congress. Hanna, Kathi E. // Hastings Center Report;Jul/Aug2001, Vol. 31 Issue 4, p9 

    Discusses the legal aspects of the stem cell research as of July 2001. Conditions set in the Dickey-Wicker amendment; Intention of the United States Department of Health and Human Services to fund research on human embryonic stem cells in 1999; Action taken by medical scientific organizations...

  • HEALTH RESEARCH: $7M in Stimulus Backs Community-Based Disparities Studies.  // Community Health Funding Week;5/15/2009, p8 

    The article reports that the U.S. Department of Health & Human Services (HHS) and the National Institutes of Health (NIH) invites applications under the program "Recovery Act Limited Competition: NCMHD Community Participation in Health Disparities Intervention Research Planning Phase" to award a...

  • HEALTH RESEARCH: Stimulus Includes $6M for Disparities Centers.  // Community Health Funding Week;5/15/2009, p9 

    The article reports that the U.S. Department of Health & Human Services and the National Institutes of Health (NIH) have invited application to award a grant of $6 million under the program "Recovery Act Limited Competition: NCMHD Dissertation Research Award to Increase Diversity (R36)." Public...

  • WORKFORCE: Stimulus Dollars Support Disparities Research Careers.  // Community Health Funding Week;5/15/2009, p17 

    The article reports that applications have been invited by the U.S. Department of Health & Human Services and the National Institutes of Health (NIH) under the program "Recovery Act Limited Competition: NCMHD Dissertation Research Award to Increase Diversity" to award funding of $500,000. The...

  • US calls for research into research integrity. Smith, Richard // BMJ: British Medical Journal (International Edition);12/02/2000, Vol. 321 Issue 7273, p1369 

    Reports that Chris Pascal, the director of the United States Office of Research Integrity has, at the first international conference on research integrity, called for research into research integrity. Decision by the U.S. National Institutes of Health (NIH) to fund such research; Information on...

  • An $80 million national research plan to attack Alzheimer's, a mind-robbing malady that may affect as many as 16 million Americans by 2050, will start this year with U.S.-sponsored studies on ways to prevent the disease in high-risk people, and treat it with an insulin nasal spray  // MondayMorning;5/21/2012, Vol. 20 Issue 21, p1 

    The article informs that the U.S. National Institutes of Health (NIH) has initiated a research worth 80 million dollar to prevent Alzheimer's disease in high-risk people. According to the U.S. Health and Human Services Department, the NIH will spend 7.9 million dollar to test an insulin nasal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics